{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:40:52Z","timestamp":1771000852905,"version":"3.50.1"},"reference-count":148,"publisher":"Zhejiang University Press","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1631\/jzus.b2300221","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T06:02:39Z","timestamp":1708063359000},"page":"106-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recent advancements in the diagnosis and treatment of acral melanoma","\u80a2\u7aef\u9ed1\u8272\u7d20\u7624\u7684\u8bca\u65ad\u548c\u6cbb\u7597\u8fdb\u5c55"],"prefix":"10.1631","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8122-592X","authenticated-orcid":false,"given":"Ahmad","family":"Alhaskawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-6239","authenticated-orcid":false,"given":"Sohaib Hasan Abdullah","family":"Ezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingtian","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnu Goutham","family":"Kota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Hasan Abdulla Hasan","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5921-1043","authenticated-orcid":false,"given":"Hui","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"22","key":"221_CR1","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1001\/jama.292.22.2771","volume":"292","author":"NR Abbasi","year":"2004","unstructured":"Abbasi NR, Shaw HM, Rigel DS, et al., 2004. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA, 292(22):2771\u20132776. https:\/\/doi.org\/10.1001\/jama.292.22.2771","journal-title":"JAMA"},{"issue":"3","key":"221_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12094-012-0951-7","volume":"15","author":"R Alemany","year":"2013","unstructured":"Alemany R, 2013. Viruses in cancer treatment. Clin Transl Oncol, 15(3):182\u2013188. https:\/\/doi.org\/10.1007\/s12094-012-0951-7","journal-title":"Clin Transl Oncol"},{"issue":"25","key":"221_CR3","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","volume":"33","author":"RHI Andtbacka","year":"2015","unstructured":"Andtbacka RHI, Kaufman HL, Collichio F, et al., 2015. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol, 33(25): 2780\u20132788. https:\/\/doi.org\/10.1200\/jco.2014.58.3377","journal-title":"J Clin Oncol"},{"issue":"31","key":"221_CR4","doi-asserted-by":"publisher","first-page":"51936","DOI":"10.18632\/oncotarget.17232","volume":"8","author":"H Arasanz","year":"2017","unstructured":"Arasanz H, Gato-Ca\u00f1as M, Zuazo M, et al., 2017. PD1 signal transduction pathways in T cells. Oncotarget, 8(31):51936\u201351945. https:\/\/doi.org\/10.18632\/oncotarget.17232","journal-title":"Oncotarget"},{"issue":"2","key":"221_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00000478-197706000-00004","volume":"1","author":"JH Arrington III","year":"1977","unstructured":"Arrington JHIII, Reed RJ, Ichinose H, et al., 1977. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol, 1(2):131\u2013143.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"221_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1470-2045(13)70024-X","volume":"14","author":"PA Ascierto","year":"2013","unstructured":"Ascierto PA, Schadendorf D, Berking C, et al., 2013. MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study. Lancet Oncol, 14(3):249\u2013256. https:\/\/doi.org\/10.1016\/s1470-2045(13)70024-x","journal-title":"Lancet Oncol"},{"key":"221_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","volume":"9","author":"BC Bastian","year":"2014","unstructured":"Bastian BC, 2014. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol: Mech Dis, 9:239\u2013271. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104658","journal-title":"Annu Rev Pathol: Mech Dis"},{"issue":"21","key":"221_CR8","doi-asserted-by":"publisher","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","volume":"14","author":"C Beadling","year":"2008","unstructured":"Beadling C, Jacobson-Dunlop E, Hodi FS, et al., 2008. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res, 14(21):6821\u20136828. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-0575","journal-title":"Clin Cancer Res"},{"issue":"5","key":"221_CR9","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jamcollsurg.2008.12.019","volume":"208","author":"GM Beasley","year":"2009","unstructured":"Beasley GM, Caudle A, Petersen RP, et al., 2009. A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US. J Am Coll Surg, 208(5): 706\u2013715. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2008.12.019","journal-title":"J Am Coll Surg"},{"issue":"11","key":"221_CR10","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1245\/s10434-013-3089-0","volume":"20","author":"DM Bello","year":"2013","unstructured":"Bello DM, Chou JF, Panageas KS, et al., 2013. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol, 20(11):3618\u20133625. https:\/\/doi.org\/10.1245\/s10434-013-3089-0","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"221_CR11","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/pcmr.12999","volume":"34","author":"SX Bian","year":"2021","unstructured":"Bian SX, Hwang L, Hwang J, et al., 2021. Acral lentiginous melanoma\u2014population, treatment, and survival using the NCDB from 2004 to 2015. Pigment Cell Melanoma Res, 34(6):1049\u20131061. https:\/\/doi.org\/10.1111\/pcmr.12999","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"221_CR12","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaad.2011.04.031","volume":"65","author":"CK Bichakjian","year":"2011","unstructured":"Bichakjian CK, Halpern AC, Johnson TM, et al., 2011. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol, 65(5):1032\u20131047. https:\/\/doi.org\/10.1016\/j.jaad.2011.04.031","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"221_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S0190-9622(94)70235-7","volume":"31","author":"AS Boyd","year":"1994","unstructured":"Boyd AS, Rapini RP, 1994. Acral melanocytic neoplasms: a histologic analysis of 158 lesions. J Am Acad Dermatol, 31(5 Pt 1):740\u2013745. https:\/\/doi.org\/10.1016\/s0190-9622(94)70235-7","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"221_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","volume":"145","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Goldstein AM, McMaster ML, et al., 2009. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986\u20132005. Arch Dermatol, 145(4): 427\u2013434. https:\/\/doi.org\/10.1001\/archdermatol.2008.609","journal-title":"Arch Dermatol"},{"issue":"7","key":"221_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.5858\/2010-0323-RAR.1","volume":"135","author":"F Bravo Puccio","year":"2011","unstructured":"Bravo Puccio F, Chian C, 2011. Acral junctional nevus versus acral lentiginous melanoma in situ: a differential diagnosis that should be based on clinicopathologic correlation. Arch Pathol Lab Med, 135(7):847\u2013852. https:\/\/doi.org\/10.5858\/2010-0323-ran.1","journal-title":"Arch Pathol Lab Med"},{"key":"221_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1757-1146-3-22","volume":"3","author":"IR Bristow","year":"2010","unstructured":"Bristow IR, de Berker DAR, 2010. Development of a practical guide for the early recognition for malignant melanoma of the foot and nail unit. J Foot Ankle Res, 3:22. https:\/\/doi.org\/10.1186\/1757-1146-3-22","journal-title":"J Foot Ankle Res"},{"issue":"S1","key":"221_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40257-018-0373-6","volume":"19","author":"R Cabrera","year":"2018","unstructured":"Cabrera R, Recule F, 2018. Unusual clinical presentations of malignant melanoma: a review of clinical and histologic features with special emphasis on dermatoscopic findings. Am J Clin Dermatol, 19(S1):15\u201323. https:\/\/doi.org\/10.1007\/s40257-018-0373-6","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"221_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1524-4725.1994.tb03711.x","volume":"20","author":"N Cascinelli","year":"1994","unstructured":"Cascinelli N, Zurrida S, Galimberti V, et al., 1994. Acral lentiginous melanoma. A histological type without prognostic significance. J Dermatol Surg Oncol, 20(12):817\u2013822. https:\/\/doi.org\/10.1111\/j.1524-4725.1994.tb03711.x","journal-title":"J Dermatol Surg Oncol"},{"issue":"12","key":"221_CR19","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1007\/s12094-017-1685-3","volume":"19","author":"CA Castaneda","year":"2017","unstructured":"Castaneda CA, Torres-Cabala C, Castillo M, et al., 2017. Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America. Clin Transl Oncol, 19(12):1478\u20131488. https:\/\/doi.org\/10.1007\/s12094-017-1685-3","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"221_CR20","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR, 1998. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer, 83(8):1664\u20131678. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19981015)83:8<1664::aid-cncr23>3.0.co;2-g","journal-title":"Cancer"},{"issue":"10","key":"221_CR21","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1093\/annonc\/mdx339","volume":"28","author":"PB Chapman","year":"2017","unstructured":"Chapman PB, Robert C, Larkin J, et al., 2017. Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study. Ann Oncol, 28(10):2581\u20132587. https:\/\/doi.org\/10.1093\/annonc\/mdx339","journal-title":"Ann Oncol"},{"issue":"17","key":"221_CR22","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1200\/JCO.2017.73.7379","volume":"36","author":"J Chesney","year":"2018","unstructured":"Chesney J, Puzanov I, Collichio F, et al., 2018. Randomized, open-label phase II study evaluating the efficacy and safety of talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone in patients with advanced, unresectable melanoma. J Clin Oncol, 36(17):1658\u20131667. https:\/\/doi.org\/10.1200\/jco.2017.73.7379","journal-title":"J Clin Oncol"},{"issue":"1","key":"221_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/bjd.13187","volume":"172","author":"SY Chuah","year":"2015","unstructured":"Chuah SY, Tsilika K, Chiaverini C, et al., 2015. Dermoscopic features of congenital acral melanocytic naevi in children: a prospective comparative and follow-up study. Br J Dermatol, 172(1):88\u201393. https:\/\/doi.org\/10.1111\/bjd.13187","journal-title":"Br J Dermatol"},{"issue":"7","key":"221_CR24","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/jdv.13399","volume":"30","author":"E Cinotti","year":"2016","unstructured":"Cinotti E, Debarbieux S, Perrot JL, et al., 2016. Reflectance confocal microscopy features of acral lentiginous melanoma: a comparative study with acral nevi. J Eur Acad Dermatol Venereol, 30(7):1125\u20131128. https:\/\/doi.org\/10.1111\/jdv.13399","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"221_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.6004\/jnccn.2016.0051","volume":"14","author":"DG Coit","year":"2016","unstructured":"Coit DG, Thompson JA, Algazi A, et al., 2016a. Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 14(4):450\u2013473. https:\/\/doi.org\/10.6004\/jnccn.2016.0051","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"221_CR26","doi-asserted-by":"publisher","first-page":"945","DOI":"10.6004\/jnccn.2016.0101","volume":"14","author":"DG Coit","year":"2016","unstructured":"Coit DG, Thompson JA, Algazi A, et al., 2016b. NCCN guidelines insights: melanoma, version 3.2016. J Natl Compr Canc Netw, 14(8):945\u2013958. https:\/\/doi.org\/10.6004\/jnccn.2016.0101","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"221_CR27","doi-asserted-by":"publisher","first-page":"367","DOI":"10.6004\/jnccn.2019.0018","volume":"17","author":"DG Coit","year":"2019","unstructured":"Coit DG, Thompson JA, Albertini MR, et al., 2019. Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 17(4):367\u2013402. https:\/\/doi.org\/10.6004\/jnccn.2019.0018","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"221_CR28","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/jdv.14712","volume":"32","author":"CM Costello","year":"2018","unstructured":"Costello CM, Ghanavatian S, Temkit M, et al., 2018. Educational and practice gaps in the management of volar melanocytic lesions. J Eur Acad Dermatol Venereol, 32(9):1450\u20131455. https:\/\/doi.org\/10.1111\/jdv.14712","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"20","key":"221_CR29","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"JA Curtin","year":"2005","unstructured":"Curtin JA, Fridlyand J, Kageshita T, et al., 2005. Distinct sets of genetic alterations in melanoma. N Engl J Med, 353(20): 2135\u20132147. https:\/\/doi.org\/10.1056\/NEJMoa050092","journal-title":"N Engl J Med"},{"issue":"26","key":"221_CR30","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"JA Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, et al., 2006. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol, 24(26):4340\u20134346. https:\/\/doi.org\/10.1200\/jco.2006.06.2984","journal-title":"J Clin Oncol"},{"issue":"3","key":"221_CR31","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jaad.2019.01.081","volume":"81","author":"CC Darmawan","year":"2019","unstructured":"Darmawan CC, Jo G, Montenegro SE, et al., 2019. Early detection of acral melanoma: a review of clinical, dermoscopic, histopathologic, and molecular characteristics. J Am Acad Dermatol, 81(3):805\u2013812. https:\/\/doi.org\/10.1016\/j.jaad.2019.01.081","journal-title":"J Am Acad Dermatol"},{"key":"221_CR32","unstructured":"De Facto, Eng.LSM.lv, 2019. Rigvir cancer treatment at center of fresh controversy. https:\/\/eng.lsm.lv"},{"issue":"2","key":"221_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/CMR.0000000000000222","volume":"26","author":"V de Lima Vazquez","year":"2016","unstructured":"de Lima Vazquez V, Vicente AL, Carloni A, et al., 2016. Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas. Melanoma Res, 26(2):93\u201399. https:\/\/doi.org\/10.1097\/cmr.0000000000000222","journal-title":"Melanoma Res"},{"issue":"2","key":"221_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jmoldx.2013.10.009","volume":"16","author":"A Diaz","year":"2014","unstructured":"Diaz A, Puig-Butill\u00e9 JA, Valera A, et al., 2014. TERT and AURKA gene copy number gains enhance the detection of acral lentiginous melanomas by fluorescence in situ hybridization. JMol Diagn, 16(2):198\u2013206. https:\/\/doi.org\/10.1016\/j.jmoldx.2013.10.009","journal-title":"TERT and AURKA gene copy number gains enhance the detection of acral lentiginous melanomas by fluorescence in situ hybridization. JMol Diagn"},{"issue":"9","key":"221_CR35","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/bjc.2014.468","volume":"111","author":"R Dobson","year":"2014","unstructured":"Dobson R, Burgess MI, Valle JW, et al., 2014. Serial surveillance of carcinoid heart disease: factors associated with echocardiographic progression and mortality. Br J Cancer, 111(9):1703\u20131709. https:\/\/doi.org\/10.1038\/bjc.2014.468","journal-title":"Br J Cancer"},{"issue":"5","key":"221_CR36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/CMR.0000000000000180","volume":"25","author":"S Doni\u0146a","year":"2015","unstructured":"Doni\u0146a S, Str\u0113le I, Proboka G, et al., 2015. Adapted ECHO-7 virus rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study. Melanoma Res, 25(5):421\u2013426. https:\/\/doi.org\/10.1097\/cmr.0000000000000180","journal-title":"Melanoma Res"},{"issue":"19","key":"221_CR37","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMoa1802357","volume":"378","author":"AMM Eggermont","year":"2018","unstructured":"Eggermont AMM, Blank CU, Mandala M, et al., 2018. Adjuvant pembrolizumab versus placebo in resected stage III melanoma. N Engl J Med, 378(19):1789\u20131801. https:\/\/doi.org\/10.1056\/NEJMoa1802357","journal-title":"N Engl J Med"},{"issue":"7","key":"221_CR38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s12094-009-0380-4","volume":"11","author":"J Espada","year":"2009","unstructured":"Espada J, Calvo MB, D\u00edaz-Prado S, et al., 2009. Wnt signalling and cancer stem cells. Clin Transl Oncol, 11(7):411\u2013427. https:\/\/doi.org\/10.1007\/s12094-009-0380-4","journal-title":"Clin Transl Oncol"},{"issue":"4","key":"221_CR39","first-page":"443","volume":"15","author":"Q Fan","year":"2015","unstructured":"Fan Q, Cohen S, John B, et al., 2015. Melanoma in situ treated with topical imiquimod for management of persistently positive margins: a review of treatment methods. Ochsner J, 15(4):443\u2013447.","journal-title":"Ochsner J"},{"issue":"23","key":"221_CR40","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, et al., 2017. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med, 376(23):2211\u20132222. https:\/\/doi.org\/10.1056\/NEJMoa1613210","journal-title":"N Engl J Med"},{"issue":"3","key":"221_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.soc.2020.02.008","volume":"29","author":"NE Farrow","year":"2020","unstructured":"Farrow NE, Leddy M, Landa K, et al., 2020. Injectable therapies for regional melanoma. Surg Oncol Clin N Am, 29(3): 433\u2013444. https:\/\/doi.org\/10.1016\/j.soc.2020.02.008","journal-title":"Surg Oncol Clin N Am"},{"issue":"3","key":"221_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/DSS.0000000000000648","volume":"42","author":"S Felton","year":"2016","unstructured":"Felton S, Taylor RS, Srivastava D, 2016. Excision margins for melanoma in situ on the head and neck. Dermatol Surg, 42(3):327\u2013334. https:\/\/doi.org\/10.1097\/dss.0000000000000648","journal-title":"Dermatol Surg"},{"key":"221_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.anndiagpath.2016.08.005","volume":"26","author":"A Fernandez-Flores","year":"2017","unstructured":"Fernandez-Flores A, Cassarino DS, 2017. Histopathological diagnosis of acral lentiginous melanoma in early stages. Ann Diagn Pathol, 26:64\u201369. https:\/\/doi.org\/10.1016\/j.anndiagpath.2016.08.005","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"221_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1203421","volume":"367","author":"KT Flaherty","year":"2012","unstructured":"Flaherty KT, Robert C, Hersey P, et al., 2012. Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med, 367(2):107\u2013114. https:\/\/doi.org\/10.1056\/NEJMoa1203421","journal-title":"N Engl J Med"},{"issue":"1","key":"221_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nbt0108-37","volume":"26","author":"SE Frew","year":"2008","unstructured":"Frew SE, Sammut SM, Shore AF, et al., 2008. Chinese health biotech and the billion-patient market. Nat Biotechnol, 26(1):37\u201353. https:\/\/doi.org\/10.1038\/nbt0108-37","journal-title":"Nat Biotechnol"},{"issue":"9","key":"221_CR46","first-page":"619","volume":"8","author":"P Friedlander","year":"2010","unstructured":"Friedlander P, Hodi FS, 2010. Advances in targeted therapy for melanoma. Clin Adv Hematol Oncol, 8(9):619\u2013627.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"10","key":"221_CR47","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/cas.13027","volume":"107","author":"H Fukuhara","year":"2016","unstructured":"Fukuhara H, Ino Y, Todo T, 2016. Oncolytic virus therapy: a new era of cancer treatment at dawn. Cancer Sci, 107(10): 1373\u20131379. https:\/\/doi.org\/10.1111\/cas.13027","journal-title":"Cancer Sci"},{"key":"221_CR48","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ejca.2019.11.014","volume":"126","author":"C Garbe","year":"2020","unstructured":"Garbe C, Amaral T, Peris K, et al., 2020. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019. Eur J Cancer, 126:141\u2013158. https:\/\/doi.org\/10.1016\/j.ejca.2019.11.014","journal-title":"Eur J Cancer"},{"key":"221_CR49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1186\/1471-2164-13-505","volume":"13","author":"JJ Gartner","year":"2012","unstructured":"Gartner JJ, Davis S, Wei XM, et al., 2012. Comparative exome sequencing of metastatic lesions provides insights into the mutational progression of melanoma. BMC Genomics, 13:505. https:\/\/doi.org\/10.1186\/1471-2164-13-505","journal-title":"BMC Genomics"},{"issue":"2","key":"221_CR50","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jmoldx.2012.10.002","volume":"15","author":"WO Greaves","year":"2013","unstructured":"Greaves WO, Verma S, Patel KP, et al., 2013. Frequency and spectrum of BRAF mutations in a retrospective, singleinstitution study of 1112 cases of melanoma. J Mol Diagn, 15(2):220\u2013226. https:\/\/doi.org\/10.1016\/j.jmoldx.2012.10.002","journal-title":"J Mol Diagn"},{"issue":"12","key":"221_CR51","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.6004\/jnccn.2014.0172","volume":"12","author":"PV Gumaste","year":"2014","unstructured":"Gumaste PV, Fleming NH, Silva I, et al., 2014. Analysis of recurrence patterns in acral versus nonacral melanoma: should histologic subtype influence treatment guidelines? J Natl Compr Canc Netw, 12(12):1706\u20131712. https:\/\/doi.org\/10.6004\/jnccn.2014.0172","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"221_CR52","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/CMR.0000000000000465","volume":"28","author":"EM H\u00e4fliger","year":"2018","unstructured":"H\u00e4fliger EM, Ramelyte E, Mangana J, et al., 2018. Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis. Melanoma Res, 28(5): 442\u2013450. https:\/\/doi.org\/10.1097\/cmr.0000000000000465","journal-title":"Melanoma Res"},{"key":"221_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2017.07.022","volume":"86","author":"O Hamid","year":"2017","unstructured":"Hamid O, Puzanov I, Dummer R, et al., 2017. Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma. Eur J Cancer, 86:37\u201345. https:\/\/doi.org\/10.1016\/j.ejca.2017.07.022","journal-title":"Eur J Cancer"},{"key":"221_CR54","doi-asserted-by":"publisher","first-page":"20503","DOI":"10.1038\/s41598-020-77425-z","volume":"10","author":"B Han","year":"2020","unstructured":"Han B, Hur K, Ohn J, et al., 2020. Acral lentiginous melanoma in situ: dermoscopic features and management strategy. Sci Rep, 10:20503. https:\/\/doi.org\/10.1038\/s41598-020-77425-z","journal-title":"Sci Rep"},{"issue":"9839","key":"221_CR55","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","volume":"380","author":"A Hauschild","year":"2012","unstructured":"Hauschild A, Grob JJ, Demidov LV, et al., 2012. Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. Lancet, 380(9839):358\u2013365. https:\/\/doi.org\/10.1016\/s0140-6736(12)60868-x","journal-title":"Lancet"},{"issue":"7653","key":"221_CR56","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, et al., 2017. Whole-genome landscapes of major melanoma subtypes. Nature, 545(7653):175\u2013180. https:\/\/doi.org\/10.1038\/nature22071","journal-title":"Nature"},{"issue":"2","key":"221_CR57","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/jid.2012.273","volume":"133","author":"A Hervieu","year":"2013","unstructured":"Hervieu A, R\u00e9b\u00e9 C, V\u00e9gran F, et al., 2013. Dacarbazinemediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth. J Invest Dermatol, 133(2):499\u2013508. https:\/\/doi.org\/10.1038\/jid.2012.273","journal-title":"J Invest Dermatol"},{"key":"221_CR58","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jss.2020.02.010","volume":"251","author":"K Huang","year":"2020","unstructured":"Huang K, Fan J, Misra S, 2020. Acral lentiginous melanoma: incidence and survival in the United States, 2006\u20132015, an analysis of the SEER registry. J Surg Res, 251:329\u2013339. https:\/\/doi.org\/10.1016\/j.jss.2020.02.010","journal-title":"J Surg Res"},{"issue":"4","key":"221_CR59","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3390\/jcm10040811","volume":"10","author":"T Ide","year":"2021","unstructured":"Ide T, Ito T, Wada-Ohno M, et al., 2021. Preoperative screening CT and PET\/CT scanning for acral melanoma: is it necessary? J Clin Med, 10(4):811. https:\/\/doi.org\/10.3390\/jcm10040811","journal-title":"J Clin Med"},{"issue":"1","key":"221_CR60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.dad.0000187931.05030.a0","volume":"28","author":"Y Ishihara","year":"2006","unstructured":"Ishihara Y, Saida T, Miyazaki A, et al., 2006. Early acral melanoma in situ: correlation between the parallel ridge pattern on dermoscopy and microscopic features. Am J Dermatopathol, 28(1):21\u201327. https:\/\/doi.org\/10.1097\/01.dad.0000187931.05030.a0","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"221_CR61","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jnci\/djj161","volume":"98","author":"H Ito","year":"2006","unstructured":"Ito H, Aoki H, K\u00fchnel F, et al., 2006. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst, 98(9):625\u2013636. https:\/\/doi.org\/10.1093\/jnci\/djj161","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"221_CR62","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jaad.2014.10.008","volume":"72","author":"T Ito","year":"2015","unstructured":"Ito T, Wada M, Nagae K, et al., 2015. Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy? J Am Acad Dermatol, 72(1):71\u201377. https:\/\/doi.org\/10.1016\/j.jaad.2014.10.008","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"221_CR63","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/nrd4663","volume":"14","author":"HL Kaufman","year":"2015","unstructured":"Kaufman HL, Kohlhapp FJ, Zloza A, 2015. Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov, 14(9):642\u2013662. https:\/\/doi.org\/10.1038\/nrd4663","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"221_CR64","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/labinvest.2017.64","volume":"97","author":"GJ Kaunitz","year":"2017","unstructured":"Kaunitz GJ, Cottrell TR, Lilo M, et al., 2017. Melanoma subtypes demonstrate distinct PD-L1 expression profiles. Lab Invest, 97(9):1063\u20131071. https:\/\/doi.org\/10.1038\/labinvest.2017.64","journal-title":"Lab Invest"},{"issue":"8","key":"221_CR65","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/cncr.11272","volume":"97","author":"D Khayat","year":"2003","unstructured":"Khayat D, Rixe O, Martin G, et al., 2003. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer, 97(8):1941\u20131946. https:\/\/doi.org\/10.1002\/cncr.11272","journal-title":"Cancer"},{"issue":"1","key":"221_CR66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1346-8138.2007.00217.x","volume":"34","author":"I Kilinc Karaarslan","year":"2007","unstructured":"Kilinc Karaarslan I, Akalin T, Unal I, et al., 2007. Atypical melanosis of the foot showing a dermoscopic feature of the parallel ridge pattern. J Dermatol, 34(1):56\u201359. https:\/\/doi.org\/10.1111\/j.1346-8138.2007.00217.x","journal-title":"J Dermatol"},{"issue":"6","key":"221_CR67","doi-asserted-by":"publisher","first-page":"779","DOI":"10.5021\/ad.2014.26.6.779","volume":"26","author":"JY Kim","year":"2014","unstructured":"Kim JY, Hwang EJ, Choi M, et al., 2014. Recurrent acral lentiginous melanoma in situ suggesting the field cell theory. Ann Dermatol, 26(6):779\u2013781. https:\/\/doi.org\/10.5021\/ad.2014.26.6.779","journal-title":"Ann Dermatol"},{"issue":"6","key":"221_CR68","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaad.2015.02.1113","volume":"72","author":"SY Kim","year":"2015","unstructured":"Kim SY, Kim SN, Hahn HJ, et al., 2015. Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma. J Am Acad Dermatol, 72(6):1036\u20131046.e2. https:\/\/doi.org\/10.1016\/j.jaad.2015.02.1113","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"221_CR69","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/cncr.10775","volume":"95","author":"JM Kirkwood","year":"2002","unstructured":"Kirkwood JM, Richards T, Zarour HM, et al., 2002. Immunomodulatory effects of high-dose and low-dose interferon \u03b12b in patients with high-risk resected melanoma: the E2690 laboratory corollary of intergroup adjuvant trial E1690. Cancer, 95(5):1101\u20131112. https:\/\/doi.org\/10.1002\/cncr.10775","journal-title":"Cancer"},{"issue":"2","key":"221_CR70","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.1016\/j.jaad.2019.09.025","volume":"83","author":"LQ Kong","year":"2020","unstructured":"Kong LQ, Tan KP, Tan HW, et al., 2020. Use of magnetic resonance imaging as a noninvasive technique to identify acral lentiginous melanoma. J Am Acad Dermatol, 83(2): e121\u2013e123. https:\/\/doi.org\/10.1016\/j.jaad.2019.09.025","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"221_CR71","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/mt.2010.161","volume":"18","author":"A Koski","year":"2010","unstructured":"Koski A, Kangasniemi L, Escutenaire S, et al., 2010. Treatment of cancer patients with a serotype 5\/3 chimeric oncolytic adenovirus expressing GMCSF. Mol Ther, 18(10): 1874\u20131884. https:\/\/doi.org\/10.1038\/mt.2010.161","journal-title":"Mol Ther"},{"issue":"6","key":"221_CR72","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/ddg.12072","volume":"11","author":"SL Kraus","year":"2013","unstructured":"Kraus SL, Haenssle HA, 2013. Early detection of cutaneous melanoma by sequential digital dermatoscopy (SDD). J Dtsch Dermatol Ges, 11(6):509\u2013512. https:\/\/doi.org\/10.1111\/ddg.12072","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"221_CR73","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jaad.2011.06.019","volume":"66","author":"JH Kunishige","year":"2012","unstructured":"Kunishige JH, Brodland DG, Zitelli JA, 2012. Surgical margins for melanoma in situ. J Am Acad Dermatol, 66(3): 438\u2013444. https:\/\/doi.org\/10.1016\/j.jaad.2011.06.019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"221_CR74","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4161\/cbt.4.5.1820","volume":"4","author":"D Kuruppu","year":"2005","unstructured":"Kuruppu D, Tanabe KK, 2005. Viral oncolysis by herpes simplex virus and other viruses. Cancer Biol Ther, 4(5): 524\u2013531. https:\/\/doi.org\/10.4161\/cbt.4.5.1820","journal-title":"Cancer Biol Ther"},{"key":"221_CR75","doi-asserted-by":"publisher","first-page":"15894","DOI":"10.1038\/s41598-019-52180-y","volume":"9","author":"MR Kwon","year":"2019","unstructured":"Kwon MR, Choi SH, Jang KT, et al., 2019. Acral malignant melanoma; emphasis on the primary metastasis and the usefulness of preoperative ultrasound for sentinel lymph node metastasis. Sci Rep, 9:15894. https:\/\/doi.org\/10.1038\/s41598-019-52180-y","journal-title":"Sci Rep"},{"issue":"4","key":"221_CR76","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/bjd.14045","volume":"173","author":"A Lallas","year":"2015","unstructured":"Lallas A, Kyrgidis A, Koga H, et al., 2015. The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanoma. Br J Dermatol, 173(4):1041\u20131049. https:\/\/doi.org\/10.1111\/bjd.14045","journal-title":"Br J Dermatol"},{"issue":"6","key":"221_CR77","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/00000372-200012000-00012","volume":"22","author":"PE LeBoit","year":"2000","unstructured":"LeBoit PE, 2000. A diagnosis for maniacs. Am J Dermatopathol, 22(6):556\u2013558. https:\/\/doi.org\/10.1097\/00000372-200012000-00012","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"221_CR78","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1365-2133.2010.10185.x","volume":"164","author":"JH Lee","year":"2011","unstructured":"Lee JH, Choi JW, Kim YS, 2011. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br J Dermatol, 164(4):776\u2013784. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.10185.x","journal-title":"Br J Dermatol"},{"issue":"8","key":"221_CR79","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/jso.24442","volume":"114","author":"KT Lee","year":"2016","unstructured":"Lee KT, Kim EJ, Lee DY, et al., 2016. Surgical excision margin for primary acral melanoma. J Surg Oncol, 114(8):933\u2013939. https:\/\/doi.org\/10.1002\/jso.24442","journal-title":"J Surg Oncol"},{"issue":"4","key":"221_CR80","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1101\/gr.213348.116","volume":"27","author":"WS Liang","year":"2017","unstructured":"Liang WS, Hendricks W, Kiefer J, et al., 2017. Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma. Genome Res, 27(4):524\u2013532. https:\/\/doi.org\/10.1101\/gr.213348.116","journal-title":"Genome Res"},{"issue":"8","key":"221_CR81","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrc3770","volume":"14","author":"BD Lichty","year":"2014","unstructured":"Lichty BD, Breitbach CJ, Stojdl DF, et al., 2014. Going viral with cancer immunotherapy. Nat Rev Cancer, 14(8): 559\u2013567. https:\/\/doi.org\/10.1038\/nrc3770","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"221_CR82","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1074-7613(00)80480-X","volume":"4","author":"PS Linsley","year":"1996","unstructured":"Linsley PS, Bradshaw J, Greene J, et al., 1996. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity, 4(6):535\u2013543. https:\/\/doi.org\/10.1016\/s1074-7613(00)80480-x","journal-title":"Immunity"},{"issue":"6","key":"221_CR83","doi-asserted-by":"publisher","first-page":"e38659","DOI":"10.1371\/journal.pone.0038659","volume":"7","author":"XY Liu","year":"2012","unstructured":"Liu XY, Fang H, Chen HC, et al., 2012. An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation. PLoS ONE, 7(6):e38659. https:\/\/doi.org\/10.1371\/journal.pone.0038659","journal-title":"PLoS ONE"},{"issue":"5","key":"221_CR84","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/01.sla.0000217745.56657.e5","volume":"244","author":"S Llanos","year":"2006","unstructured":"Llanos S, Danilla S, Barraza C, et al., 2006. Effectiveness of negative pressure closure in the integration of split thickness skin grafts: a randomized, double-masked, controlled trial. Ann Surg, 244(5):700\u2013705. https:\/\/doi.org\/10.1097\/01.sla.0000217745.56657.e5","journal-title":"Ann Surg"},{"issue":"19","key":"221_CR85","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","volume":"377","author":"GV Long","year":"2017","unstructured":"Long GV, Hauschild A, Santinami M, et al., 2017a. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med, 377(19):1813\u20131823. https:\/\/doi.org\/10.1056\/NEJMoa1708539","journal-title":"N Engl J Med"},{"issue":"7","key":"221_CR86","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/annonc\/mdx176","volume":"28","author":"GV Long","year":"2017","unstructured":"Long GV, Flaherty KT, Stroyakovskiy D, et al., 2017b. Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E\/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. Ann Oncol, 28(7): 1631\u20131639. https:\/\/doi.org\/10.1093\/annonc\/mdx176","journal-title":"Ann Oncol"},{"issue":"1","key":"221_CR87","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1524-4725.2012.02569.x","volume":"39","author":"MP Loosemore","year":"2013","unstructured":"Loosemore MP, Morales-Burgos A, Goldberg LH, 2013. Acral lentiginous melanoma of the toe treated using Mohs surgery with sparing of the digit and subsequent reconstruction using split-thickness skin graft. Dermatol Surg, 39(1 Pt 1): 136\u2013138. https:\/\/doi.org\/10.1111\/j.1524-4725.2012.02569.x","journal-title":"Dermatol Surg"},{"issue":"24","key":"221_CR88","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/jnci\/djg123","volume":"95","author":"JL Maldonado","year":"2003","unstructured":"Maldonado JL, Fridlyand J, Patel H, et al., 2003. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst, 95(24):1878\u20131890. https:\/\/doi.org\/10.1093\/jnci\/djg123","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"221_CR89","doi-asserted-by":"publisher","first-page":"237","DOI":"10.21037\/atm.2016.06.07","volume":"4","author":"JL Manzano","year":"2016","unstructured":"Manzano JL, Layos L, Bug\u00e9s C, et al., 2016. Resistant mechanisms to BRAF inhibitors in melanoma. Ann Transl Med, 4(12):237. https:\/\/doi.org\/10.21037\/atm.2016.06.07","journal-title":"Ann Transl Med"},{"issue":"7","key":"221_CR90","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jamadermatol.2016.0875","volume":"152","author":"AJ Marek","year":"2016","unstructured":"Marek AJ, Ming ME, Bartlett EK, et al., 2016. Acral lentiginous histologic subtype and sentinel lymph node positivity in thin melanoma. JAMA Dermatol, 152(7):836\u2013837. https:\/\/doi.org\/10.1001\/jamadermatol.2016.0875","journal-title":"JAMA Dermatol"},{"issue":"5","key":"221_CR91","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/bjd.13485","volume":"172","author":"D Menis","year":"2015","unstructured":"Menis D, Maro\u00f1as-Jim\u00e9nez L, Rodr\u00edguez-Peralto J, et al., 2015. Two Spanish cases of atypical melanosis of the foot, an early stage of acral lentiginous melanoma in situ. Br J Dermatol, 172(5):1436\u20131438. https:\/\/doi.org\/10.1111\/bjd.13485","journal-title":"Br J Dermatol"},{"issue":"2","key":"221_CR92","doi-asserted-by":"publisher","first-page":"60","DOI":"10.12788\/j.sder.0081","volume":"33","author":"DM Miller","year":"2014","unstructured":"Miller DM, Flaherty KT, Tsao H, 2014. Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma. Semin Cutan Med Surg, 33(2):60\u201367. https:\/\/doi.org\/10.12788\/j.sder.0081","journal-title":"Semin Cutan Med Surg"},{"issue":"5","key":"221_CR93","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jaad.2018.06.004","volume":"79","author":"JH Mun","year":"2018","unstructured":"Mun JH, Jo G, Darmawan CC, et al., 2018. Association between Breslow thickness and dermoscopic findings in acral melanoma. J Am Acad Dermatol, 79(5):831\u2013835. https:\/\/doi.org\/10.1016\/j.jaad.2018.06.004","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"221_CR94","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11864-018-0560-y","volume":"19","author":"Y Nakamura","year":"2018","unstructured":"Nakamura Y, Fujisawa Y, 2018. Diagnosis and management of acral lentiginous melanoma. Curr Treat Options Oncol, 19(8):42. https:\/\/doi.org\/10.1007\/s11864-018-0560-y","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"221_CR95","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jdermsci.2017.12.016","volume":"90","author":"Y Nakamura","year":"2018","unstructured":"Nakamura Y, Fujisawa Y, Okiyama N, et al., 2018. Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response. J Dermatol Sci, 90(1):46\u201351. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.12.016","journal-title":"J Dermatol Sci"},{"issue":"3","key":"221_CR96","first-page":"268","volume":"16","author":"J Ocampo-Garza","year":"2017","unstructured":"Ocampo-Garza J, di Chiacchio NG, Haneke E, et al., 2017. Subungual melanoma in situ treated with imiquimod 5% cream after conservative surgery recurrence. J Drugs Dermatol, 16(3):268\u2013270.","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"221_CR97","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/1346-8138.14324","volume":"45","author":"D Ogata","year":"2018","unstructured":"Ogata D, Arai E, Goto Y, et al., 2018. Pilot study on the correlation between dermoscopic patterns and fluorescence in situ hybridization findings using whole-slide digital imaging for acral volar melanocytic lesions. J Dermatol, 45(7):830\u2013836. https:\/\/doi.org\/10.1111\/1346-8138.14324","journal-title":"J Dermatol"},{"issue":"2","key":"221_CR98","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/bjd.12099","volume":"168","author":"BH Oh","year":"2013","unstructured":"Oh BH, Lee SH, Nam KA, et al., 2013. Comparison of negative pressure wound therapy and secondary intention healing after excision of acral lentiginous melanoma on the foot. Br J Dermatol, 168(2):333\u2013338. https:\/\/doi.org\/10.1111\/bjd.12099","journal-title":"Br J Dermatol"},{"issue":"3","key":"221_CR99","doi-asserted-by":"publisher","first-page":"400","DOI":"10.5021\/ad.2011.23.3.400","volume":"23","author":"TS Oh","year":"2011","unstructured":"Oh TS, Bae EJ, Ro KW, et al., 2011. Acral lentiginous melanoma developing during long-standing atypical melanosis: usefulness of dermoscopy for detection of early acral melanoma. Ann Dermatol, 23(3):400\u2013404. https:\/\/doi.org\/10.5021\/ad.2011.23.3.400","journal-title":"Ann Dermatol"},{"issue":"12","key":"221_CR100","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1158\/1078-0432.CCR-10-2917","volume":"17","author":"K Omholt","year":"2011","unstructured":"Omholt K, Grafstr\u00f6m E, Kanter-Lewensohn L, et al., 2011. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res, 17(12):3933\u20133942. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-2917","journal-title":"Clin Cancer Res"},{"issue":"1","key":"221_CR101","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/pcmr.12041","volume":"26","author":"JL Orgaz","year":"2013","unstructured":"Orgaz JL, Sanz-Moreno V, 2013. Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell Melanoma Res, 26(1):39\u201357. https:\/\/doi.org\/10.1111\/pcmr.12041","journal-title":"Pigment Cell Melanoma Res"},{"issue":"10","key":"221_CR102","doi-asserted-by":"publisher","first-page":"981","DOI":"10.4065\/mcp.2011.0287","volume":"86","author":"SR Palmer","year":"2011","unstructured":"Palmer SR, Erickson LA, Ichetovkin I, et al., 2011. Circulating serologic and molecular biomarkers in malignant melanoma. Mayo Clin Proc, 86(10):981\u2013990. https:\/\/doi.org\/10.4065\/mcp.2011.0287","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"221_CR103","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/cancers2020642","volume":"2","author":"HS Park","year":"2010","unstructured":"Park HS, Cho KH, 2010. Acral lentiginous melanoma in situ: a diagnostic and management challenge. Cancers, 2(2): 642\u2013652. https:\/\/doi.org\/10.3390\/cancers2020642","journal-title":"Cancers"},{"issue":"5","key":"221_CR104","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1200\/JOP.18.00063","volume":"14","author":"JA Perone","year":"2018","unstructured":"Perone JA, Farrow N, Tyler DS, et al., 2018. Contemporary approaches to in-transit melanoma. J Oncol Pract, 14(5): 292\u2013300. https:\/\/doi.org\/10.1200\/jop.18.00063","journal-title":"J Oncol Pract"},{"issue":"4","key":"221_CR105","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1365-2133.2009.09594.x","volume":"162","author":"A Phan","year":"2010","unstructured":"Phan A, Dalle S, Touzet S, et al., 2010. Dermoscopic features of acral lentiginous melanoma in a large series of 110 cases in a white population. Br J Dermatol, 162(4):765\u2013771. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09594.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"221_CR106","doi-asserted-by":"publisher","first-page":"e1115641","DOI":"10.1080\/2162402X.2015.1115641","volume":"5","author":"J Pol","year":"2016","unstructured":"Pol J, Kroemer G, Galluzzi L, 2016. First oncolytic virus approved for melanoma immunotherapy. Oncoimmunology, 5(1):e1115641. https:\/\/doi.org\/10.1080\/2162402x.2015.1115641","journal-title":"Oncoimmunology"},{"issue":"3","key":"221_CR107","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1053\/j.seminoncol.2015.02.012","volume":"42","author":"I Rafique","year":"2015","unstructured":"Rafique I, Kirkwood JM, Tarhini AA, 2015. Immune checkpoint blockade and interferon-\u03b1 in melanoma. Semin Oncol, 42(3):436\u2013447. https:\/\/doi.org\/10.1053\/j.seminoncol.2015.02.012","journal-title":"Semin Oncol"},{"issue":"2","key":"221_CR108","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10103-018-2696-1","volume":"34","author":"A Rajabi-Estarabadi","year":"2019","unstructured":"Rajabi-Estarabadi A, Bittar JM, Zheng CW, et al., 2019. Optical coherence tomography imaging of melanoma skin cancer. Lasers Med Sci, 34(2):411\u2013420. https:\/\/doi.org\/10.1007\/s10103-018-2696-1","journal-title":"Lasers Med Sci"},{"issue":"5","key":"221_CR109","doi-asserted-by":"publisher","first-page":"567","DOI":"10.23736\/S0392-0488.18.05791-7","volume":"154","author":"GM Ravaioli","year":"2019","unstructured":"Ravaioli GM, Dika E, Lambertini M, et al., 2019. Acral melanoma: correlating the clinical presentation to the mutational status. G Ital Dermatol Venereol, 154(5):567\u2013572. https:\/\/doi.org\/10.23736\/s0392-0488.18.05791-7","journal-title":"G Ital Dermatol Venereol"},{"issue":"6","key":"221_CR110","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cell.2017.08.027","volume":"170","author":"A Ribas","year":"2017","unstructured":"Ribas A, Dummer R, Puzanov I, et al., 2017. Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy. Cell, 170(6):1109\u20131119.e10. https:\/\/doi.org\/10.1016\/j.cell.2017.08.027","journal-title":"Cell"},{"issue":"1","key":"221_CR111","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/archsurg.1995.01430010090019","volume":"130","author":"CA Ridgeway","year":"1995","unstructured":"Ridgeway CA, Hieken TJ, Ronan SG, et al., 1995. Acral lentiginous melanoma. Arch Surg, 130(1):88\u201392. https:\/\/doi.org\/10.1001\/archsurg.1995.01430010090019","journal-title":"Arch Surg"},{"issue":"26","key":"221_CR112","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","volume":"364","author":"C Robert","year":"2011","unstructured":"Robert C, Thomas L, Bondarenko I, et al., 2011. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med, 364(26):2517\u20132526. https:\/\/doi.org\/10.1056\/NEJMoa1104621","journal-title":"N Engl J Med"},{"issue":"4","key":"221_CR113","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Long GV, Brady B, et al., 2015. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med, 372(4):320\u2013330. https:\/\/doi.org\/10.1056\/NEJMoa1412082","journal-title":"N Engl J Med"},{"issue":"2","key":"221_CR114","doi-asserted-by":"publisher","first-page":"63","DOI":"10.31083\/j.fbl2702063","volume":"27","author":"C Robinson","year":"2022","unstructured":"Robinson C, Xu MM, Nair SK, et al., 2022. Oncolytic viruses in melanoma. Front Biosci, 27(2):63. https:\/\/doi.org\/10.31083\/j.fbl2702063","journal-title":"Front Biosci"},{"issue":"5","key":"221_CR115","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1684\/ejd.2017.3069","volume":"27","author":"I Russo","year":"2017","unstructured":"Russo I, Zorzetto L, Frigo AC, et al., 2017. A comparative study of the cutaneous side effects between BRAF monotherapy and BRAF\/MEK inhibitor combination therapy in patients with advanced melanoma: a single-centre experience. Eur J Dermatol, 27(5):482\u2013486. https:\/\/doi.org\/10.1684\/ejd.2017.3069","journal-title":"Eur J Dermatol"},{"issue":"2","key":"221_CR116","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/00000372-198911020-00003","volume":"11","author":"T Saida","year":"1989","unstructured":"Saida T, 1989. Malignant melanoma in situ on the sole of the foot. Its clinical and histopathologic characteristics. Am J Dermatopathol, 11(2):124\u2013130. https:\/\/doi.org\/10.1097\/00000372-198911020-00003","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"221_CR117","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1001\/archderm.143.11.1423","volume":"143","author":"T Saida","year":"2007","unstructured":"Saida T, Koga H, 2007. Dermoscopic patterns of acral melanocytic nevi: their variations, changes, and significance. Arch Dermatol, 143(11):1423\u20131426. https:\/\/doi.org\/10.1001\/archderm.143.11.1423","journal-title":"Arch Dermatol"},{"issue":"1","key":"221_CR118","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1346-8138.2010.01174.x","volume":"38","author":"T Saida","year":"2011","unstructured":"Saida T, Koga H, Uhara H, 2011. Key points in dermoscopic differentiation between early acral melanoma and acral nevus. J Dermatol, 38(1):25\u201334. https:\/\/doi.org\/10.1111\/j.1346-8138.2010.01174.x","journal-title":"J Dermatol"},{"issue":"33","key":"221_CR119","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.1200\/JCO.2008.21.4882","volume":"27","author":"A Sanki","year":"2009","unstructured":"Sanki A, Uren RF, Moncrieff M, et al., 2009. Targeted highresolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma. J Clin Oncol, 27(33):5614\u20135619. https:\/\/doi.org\/10.1200\/jco.2008.21.4882","journal-title":"J Clin Oncol"},{"issue":"1","key":"221_CR120","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ced.12469","volume":"40","author":"I Savarese","year":"2015","unstructured":"Savarese I, Papi F, D\u2019Errico A, et al., 2015. Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells. Clin Exp Dermatol, 40(1):27\u201330. https:\/\/doi.org\/10.1111\/ced.12469","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"221_CR121","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1440-0960.2006.00230.x","volume":"47","author":"RA Scolyer","year":"2006","unstructured":"Scolyer RA, Thompson JF, McCarthy SW, et al., 2006. Letters to the editor. Australas J Dermatol, 47(1):71\u201373. https:\/\/doi.org\/10.1111\/j.1440-0960.2006.00230.x","journal-title":"Australas J Dermatol"},{"issue":"3","key":"221_CR122","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0360-3016(99)00066-8","volume":"44","author":"MH Seegenschmiedt","year":"1999","unstructured":"Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, et al., 1999. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience. Int J Radiat Oncol Biol Phys, 44(3):607\u2013618. https:\/\/doi.org\/10.1016\/s0360-3016(99)00066-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"34","key":"221_CR123","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.1200\/JCO.2009.24.3675","volume":"27","author":"NN Senzer","year":"2009","unstructured":"Senzer NN, Kaufman HL, Amatruda T, et al., 2009. Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma. J Clin Oncol, 27(34):5763\u20135771. https:\/\/doi.org\/10.1200\/jco.2009.24.3675","journal-title":"J Clin Oncol"},{"issue":"2","key":"221_CR124","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1097\/DSS.0000000000002827","volume":"47","author":"J Seo","year":"2021","unstructured":"Seo J, Oh Y, Kim SK, et al., 2021. Slow Mohs micrographic surgery for acral melanoma treatment in Korean patients. Dermatol Surg, 47(2):e42\u2013e46. https:\/\/doi.org\/10.1097\/DSS.0000000000002827","journal-title":"Dermatol Surg"},{"issue":"3","key":"221_CR125","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1443","volume":"8","author":"AH Sharpe","year":"2007","unstructured":"Sharpe AH, Wherry EJ, Ahmed R, et al., 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol, 8(3):239\u2013245. https:\/\/doi.org\/10.1038\/ni1443","journal-title":"Nat Immunol"},{"issue":"3","key":"221_CR126","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00000478-199903000-00006","volume":"23","author":"S Signoretti","year":"1999","unstructured":"Signoretti S, Annessi G, Puddu P, et al., 1999. Melanocytic nevi of palms and soles: a histological study according to the plane of section. Am J Surg Pathol, 23(3):283\u2013287. https:\/\/doi.org\/10.1097\/00000478-199903000-00006","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"221_CR127","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.pathol.2017.08.006","volume":"49","author":"J Su","year":"2017","unstructured":"Su J, Yu WJ, Liu JY, et al., 2017. Fluorescence in situ hybridisation as an ancillary tool in the diagnosis of acral melanoma: a review of 44 cases. Pathology, 49(7):740\u2013749. https:\/\/doi.org\/10.1016\/j.pathol.2017.08.006","journal-title":"Pathology"},{"issue":"1","key":"221_CR128","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","volume":"80","author":"SM Swetter","year":"2019","unstructured":"Swetter SM, Tsao H, Bichakjian CK, et al., 2019. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol, 80(1):208\u2013250. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.055","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"221_CR129","doi-asserted-by":"publisher","first-page":"364","DOI":"10.6004\/jnccn.2021.0018","volume":"19","author":"SM Swetter","year":"2021","unstructured":"Swetter SM, Thompson JA, Albertini MR, et al., 2021. NCCN Guidelines\u2221 insights: melanoma: cutaneous, version 2.2021. J Natl Compr Canc Netw, 19(4):364\u2013376. https:\/\/doi.org\/10.6004\/jnccn.2021.0018","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"221_CR130","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/ijc.23812","volume":"123","author":"Y Takahashi","year":"2008","unstructured":"Takahashi Y, Nishikawa M, Suehara T, et al., 2008. Gene silencing of \u03b2-catenin in melanoma cells retards their growth but promotes the formation of pulmonary metastasis in mice. Int J Cancer, 123(10):2315\u20132320. https:\/\/doi.org\/10.1002\/ijc.23812","journal-title":"Int J Cancer"},{"issue":"1","key":"221_CR131","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1346-8138.2010.01128.x","volume":"38","author":"M Tanioka","year":"2011","unstructured":"Tanioka M, 2011. Benign acral lesions showing parallel ridge pattern on dermoscopy. J Dermatol, 38(1):41\u201344. https:\/\/doi.org\/10.1111\/j.1346-8138.2010.01128.x","journal-title":"J Dermatol"},{"issue":"2","key":"221_CR132","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/bjd.15803","volume":"178","author":"Y Teramoto","year":"2018","unstructured":"Teramoto Y, Keim U, Gesierich A, et al., 2018. Acral lentiginous melanoma: a skin cancer with unfavourable prognostic features. A study of the German central malignant melanoma registry (CMMR) in 2050 patients. Br J Dermatol, 178(2): 443\u2013451. https:\/\/doi.org\/10.1111\/bjd.15803","journal-title":"Br J Dermatol"},{"issue":"2","key":"221_CR133","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jdin.2020.07.004","volume":"1","author":"BM Tod","year":"2020","unstructured":"Tod BM, Schneider JW, Bowcock AM, et al., 2020. The tumor genetics of acral melanoma: what should a dermatologist know? JAAD Int, 1(2):135\u2013147. https:\/\/doi.org\/10.1016\/j.jdin.2020.07.004","journal-title":"JAAD Int"},{"issue":"6","key":"221_CR134","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1371\/journal.pmed.0050120","volume":"5","author":"A Viros","year":"2008","unstructured":"Viros A, Fridlyand J, Bauer J, et al., 2008. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med, 5(6):e120. https:\/\/doi.org\/10.1371\/journal.pmed.0050120","journal-title":"PLoS Med"},{"issue":"8","key":"221_CR135","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/1346-8138.13834","volume":"44","author":"M Wada","year":"2017","unstructured":"Wada M, Ito T, Tsuji G, et al., 2017. Acral lentiginous melanoma versus other melanoma: a single-center analysis in Japan. J Dermatol, 44(8):932\u2013938. https:\/\/doi.org\/10.1111\/1346-8138.13834","journal-title":"J Dermatol"},{"issue":"5","key":"221_CR136","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1158\/1078-0432.CCR-06-1387","volume":"13","author":"WJ Wang","year":"2007","unstructured":"Wang WJ, Edington HD, Rao UNM, et al., 2007. Modulation of signal transducers and activators of transcription 1 and 3 signaling in melanoma by high-dose IFN\u03b1b. Clin Cancer Res, 13(5):1523\u20131531. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-1387","journal-title":"Clin Cancer Res"},{"issue":"2","key":"221_CR137","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<288::AID-CNCR13>3.0.CO;2-S","volume":"86","author":"W Weyers","year":"1999","unstructured":"Weyers W, Euler M, Diaz-Cascajo C, et al., 1999. Classification of cutaneous malignant melanoma: a reassessment of histopathologic criteria for the distinction of different types. Cancer, 86(2):288\u2013299. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19990715)86:2<288::aid-cncr13>3.0.co;2-s","journal-title":"Cancer"},{"issue":"12","key":"221_CR138","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.1128\/JVI.03311-12","volume":"87","author":"G Wollmann","year":"2013","unstructured":"Wollmann G, Davis JN, Bosenberg MW, et al., 2013. Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes. J Virol, 87(12): 6644\u20136659. https:\/\/doi.org\/10.1128\/jvi.03311-12","journal-title":"J Virol"},{"issue":"5","key":"221_CR139","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bcp.2010.04.032","volume":"80","author":"SE Woodman","year":"2010","unstructured":"Woodman SE, Davies MA, 2010. Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics. Biochem Pharmacol, 80(5):568\u2013574. https:\/\/doi.org\/10.1016\/j.bcp.2010.04.032","journal-title":"Biochem Pharmacol"},{"issue":"5Suppl1","key":"221_CR140","doi-asserted-by":"publisher","first-page":"S26.e1","DOI":"10.1016\/j.jaad.2011.05.034","volume":"65","author":"XC Wu","year":"2011","unstructured":"Wu XC, Eide MJ, King J, et al., 2011. Racial and ethnic variations in incidence and survival of cutaneous melanoma in the United States, 1999\u20132006. J Am Acad Dermatol, 65(5 Suppl 1):S26.e1\u2013S37.e13. https:\/\/doi.org\/10.1016\/j.jaad.2011.05.034","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"221_CR141","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/dna.2014.2590","volume":"34","author":"SX Xu","year":"2015","unstructured":"Xu SX, Yang ZZ, Zhang JY, et al., 2015. Increased levels of \u03b2-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2. DNA Cell Biol, 34(1):69\u201377. https:\/\/doi.org\/10.1089\/dna.2014.2590","journal-title":"DNA Cell Biol"},{"issue":"1","key":"221_CR142","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/cmr.0000000000000091","volume":"25","author":"N Yamazaki","year":"2015","unstructured":"Yamazaki N, Tanaka R, Tsutsumida A, et al., 2015. BRAF V600 mutations and pathological features in Japanese melanoma patients. Melanoma Res, 25(1):9\u201314. https:\/\/doi.org\/10.1097\/cmr.0000000000000091","journal-title":"BRAF V600 mutations and pathological features in Japanese melanoma patients. Melanoma Res"},{"issue":"5","key":"221_CR143","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/genes14051021","volume":"14","author":"TT Yang","year":"2023","unstructured":"Yang TT, Yu S, Ke CK, et al., 2023. The genomic landscape of melanoma and its therapeutic implications. Genes (Basel), 14(5):1021. https:\/\/doi.org\/10.3390\/genes14051021","journal-title":"Genes (Basel)"},{"issue":"5","key":"221_CR144","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3892\/ol.2011.324","volume":"2","author":"ZZ Yang","year":"2011","unstructured":"Yang ZZ, Xie L, Huang YC, et al., 2011. Clinical features of malignant melanoma of the finger and therapeutic efficacies of different treatments. Oncol Lett, 2(5):811\u2013815. https:\/\/doi.org\/10.3892\/ol.2011.324","journal-title":"Oncol Lett"},{"issue":"10","key":"221_CR145","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/jnci\/djz005","volume":"111","author":"I Yeh","year":"2019","unstructured":"Yeh I, Jorgenson E, Shen L, et al., 2019. Targeted genomic profiling of acral melanoma. J Natl Cancer Inst, 111(10): 1068\u20131077. https:\/\/doi.org\/10.1093\/jnci\/djz005","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"221_CR146","doi-asserted-by":"publisher","first-page":"83","DOI":"10.7196\/SAMJ.2017.v107i1.10924","volume":"107","author":"K York","year":"2016","unstructured":"York K, Dlova NC, Wright CY, et al., 2016. Primary cutaneous malignancies in the Northern Cape Province of South Africa: a retrospective histopathological review. S Afr Med J, 107(1):83\u201388. https:\/\/doi.org\/10.7196\/SAMJ.2016.v107.i1.10924","journal-title":"S Afr Med J"},{"issue":"3","key":"221_CR147","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jdermsci.2013.07.013","volume":"72","author":"A Zebary","year":"2013","unstructured":"Zebary A, Omholt K, Vassilaki I, et al., 2013. KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma. J Dermatol Sci, 72(3):284\u2013289. https:\/\/doi.org\/10.1016\/j.jdermsci.2013.07.013","journal-title":"J Dermatol Sci"},{"key":"221_CR148","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/0717-6287-47-34","volume":"47","author":"VB Zemelman","year":"2014","unstructured":"Zemelman VB, Valenzuela CY, Sazunic I, et al., 2014. Malignant melanoma in Chile: different site distribution between private and state patients. Biol Res, 47:34. https:\/\/doi.org\/10.1186\/0717-6287-47-34","journal-title":"Biol Res"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2300221\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2300221.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T10:05:59Z","timestamp":1708337159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2300221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":148,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["221"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2300221","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"9 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ahmad ALHASKAWI, Sohaib Hasan Abdullah EZZI, Yanzhao DONG, Haiying ZHOU, Zewei WANG, Jingtian LAI, Chengjun YAO, Vishnu Goutham KOTA, Mohamed Hasan Abdulla Hasan ABDULLA, and Hui LU declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}